Latest Ekso Bionics Holding (EKSO) Headlines
Post# of 40
Posted On: 03/09/2014 5:31:52 PM
Latest Ekso Bionics Holding (EKSO) Headlines
3D Systems and Ekso Bionics(TM) Announce First "Bespoke" Exoskeleton
GlobeNewswire - Wed Feb 19, 5:33PM CST
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it recently debuted the first ever 3D printed hybrid exoskeleton robotic suit, in collaboration with 3D Systems (NYSE
DD), at a Singularity University event in Budapest. Designers from 3D Systems created personalized three-dimensional elements from multiple 3D scans taken of Ekso Ambassador, Amanda Boxtel.
RE2, Inc. Awarded Contract to Develop Exoskeleton Simulator
Marketwire - Wed Feb 19, 7:03AM CST
RE2, Inc. announced today that the company has been awarded a Phase I Small Business Innovation Research (SBIR) program with the U.S. Army to develop the Biomechanical Exoskeleton Simulator System, a software tool to assess the impact of load carriage and body-wearable robotic devices on musculoskeletal health and performance. RE2 is partnering with biomechanical exoskeleton experts at Ekso Bionics(TM) (OTCBB: EKSO) and neuromusculoskeletal simulation leader, Dr. Scott Delp, faculty at Stanford University.
Ekso Bionics(TM) Named One of "5 Startups Poised to Change MedTech Forever"
GlobeNewswire - Thu Feb 13, 4:00PM CST
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it was named one of five startups poised to change MedTech forever by Medical Device & Diagnostic Industry Magazine. MD+DI 's editorial quality and reliability has won it an unparalleled degree of trust from the industry. For more than 30 years, MD+DI has served the industry as the leading source of in-depth news and information; many of their articles have become standards of reference for the medical device industry.
Robotics Maker Ekso Aims to Help Wheelchair-Bound to Walk
at The Street - Fri Feb 07, 11:24AM CST
The newly public company has raised $20.6 million in new capital to develop and sell its technology.
Ekso Bionics(TM) Completes Private Placement, Raising $30.3M
GlobeNewswire - Thu Feb 06, 7:01PM CST
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it completed its private placement offering as part of its January 15, 2014 announced alternative public offering ("APO"). Shares of the Company's common stock are currently quoted on the OTC Markets under the symbol "EKSO."
Robotic Exoskeleton Innovator Ekso Bionics(TM) Goes Public, Raises $20.6M
GlobeNewswire - Wed Jan 15, 4:11PM CST
via PRWEB - Ekso Bionics Holdings, Inc. (formerly PN Med Group, Inc.) (OTCBB:EKSO), a Nevada corporation (the "Company"), announced today that it completed an alternative public offering on January 15, 2014, in which Ekso Bionics, Inc., a Delaware corporation ("Ekso Bionics"), became a wholly owned subsidiary of the Company, and completed a simultaneous $20.6 million private placement offering. Shares of the Company's common stock are currently quoted on the OTC Markets under the symbol "EKSO."
3D Systems and Ekso Bionics(TM) Announce First "Bespoke" Exoskeleton
GlobeNewswire - Wed Feb 19, 5:33PM CST
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it recently debuted the first ever 3D printed hybrid exoskeleton robotic suit, in collaboration with 3D Systems (NYSE
DD), at a Singularity University event in Budapest. Designers from 3D Systems created personalized three-dimensional elements from multiple 3D scans taken of Ekso Ambassador, Amanda Boxtel. RE2, Inc. Awarded Contract to Develop Exoskeleton Simulator
Marketwire - Wed Feb 19, 7:03AM CST
RE2, Inc. announced today that the company has been awarded a Phase I Small Business Innovation Research (SBIR) program with the U.S. Army to develop the Biomechanical Exoskeleton Simulator System, a software tool to assess the impact of load carriage and body-wearable robotic devices on musculoskeletal health and performance. RE2 is partnering with biomechanical exoskeleton experts at Ekso Bionics(TM) (OTCBB: EKSO) and neuromusculoskeletal simulation leader, Dr. Scott Delp, faculty at Stanford University.
Ekso Bionics(TM) Named One of "5 Startups Poised to Change MedTech Forever"
GlobeNewswire - Thu Feb 13, 4:00PM CST
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it was named one of five startups poised to change MedTech forever by Medical Device & Diagnostic Industry Magazine. MD+DI 's editorial quality and reliability has won it an unparalleled degree of trust from the industry. For more than 30 years, MD+DI has served the industry as the leading source of in-depth news and information; many of their articles have become standards of reference for the medical device industry.
Robotics Maker Ekso Aims to Help Wheelchair-Bound to Walk
at The Street - Fri Feb 07, 11:24AM CST
The newly public company has raised $20.6 million in new capital to develop and sell its technology.
Ekso Bionics(TM) Completes Private Placement, Raising $30.3M
GlobeNewswire - Thu Feb 06, 7:01PM CST
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today announced that it completed its private placement offering as part of its January 15, 2014 announced alternative public offering ("APO"). Shares of the Company's common stock are currently quoted on the OTC Markets under the symbol "EKSO."
Robotic Exoskeleton Innovator Ekso Bionics(TM) Goes Public, Raises $20.6M
GlobeNewswire - Wed Jan 15, 4:11PM CST
via PRWEB - Ekso Bionics Holdings, Inc. (formerly PN Med Group, Inc.) (OTCBB:EKSO), a Nevada corporation (the "Company"), announced today that it completed an alternative public offering on January 15, 2014, in which Ekso Bionics, Inc., a Delaware corporation ("Ekso Bionics"), became a wholly owned subsidiary of the Company, and completed a simultaneous $20.6 million private placement offering. Shares of the Company's common stock are currently quoted on the OTC Markets under the symbol "EKSO."
(0)
(0)